KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Depreciation and Depletion (2016 - 2026)

West Pharmaceutical Services has reported Depreciation and Depletion over the past 18 years, most recently at $44.6 million for Q1 2026.

  • Quarterly Depreciation and Depletion rose 14.07% to $44.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $174.1 million through Mar 2026, up 11.46% year-over-year, with the annual reading at $168.6 million for FY2025, 11.07% up from the prior year.
  • Depreciation and Depletion was $44.6 million for Q1 2026 at West Pharmaceutical Services, down from $46.4 million in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $46.4 million in Q4 2025 and troughed at $28.7 million in Q1 2022.
  • The 5-year median for Depreciation and Depletion is $34.8 million (2023), against an average of $36.2 million.
  • Biggest five-year swings in Depreciation and Depletion: fell 6.81% in 2022 and later increased 20.42% in 2023.
  • Tracing WST's Depreciation and Depletion over 5 years: stood at $30.1 million in 2022, then rose by 14.95% to $34.6 million in 2023, then rose by 15.03% to $39.8 million in 2024, then increased by 16.58% to $46.4 million in 2025, then decreased by 3.88% to $44.6 million in 2026.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $44.6 million, $46.4 million, and $42.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.